Compare, Analyse GSK Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
GSK PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,595347-   
Low Rs1,253251-   
Sales per share (Unadj.) Rs184.7103.3-  
Earnings per share (Unadj.) Rs26.3-26.0-  
Cash flow per share (Unadj.) Rs29.2-21.6-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.381.1-  
Shares outstanding (eoy) m169.40168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.12.9 453.7%   
Avg P/E ratio x92.2-11.5 -802.9%  
P/CF ratio (eoy) x83.1-13.9 -599.9%  
Price / Book Value ratio x19.23.7 520.6%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,62650,448 814.0%   
No. of employees `0005.04.3 115.5%   
Total wages/salary Rs m5,3723,166 169.7%   
Avg. sales/employee Rs Th6,306.74,061.4 155.3%   
Avg. wages/employee Rs Th1,083.1737.5 146.9%   
Avg. net profit/employee Rs Th898.0-1,023.4 -87.7%   
INCOME DATA
Net Sales Rs m31,28117,436 179.4%  
Other income Rs m1,023122 838.0%   
Total revenues Rs m32,30417,558 184.0%   
Gross profit Rs m6,009-3,021 -198.9%  
Depreciation Rs m486753 64.6%   
Interest Rs m6472 1.3%   
Profit before tax Rs m6,540-4,124 -158.6%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,373258 920.8%   
Profit after tax Rs m4,454-4,393 -101.4%  
Gross profit margin %19.2-17.3 -110.8%  
Effective tax rate %36.3-6.2 -580.7%   
Net profit margin %14.2-25.2 -56.5%  
BALANCE SHEET DATA
Current assets Rs m20,06112,770 157.1%   
Current liabilities Rs m14,5437,185 202.4%   
Net working cap to sales %17.632.0 55.1%  
Current ratio x1.41.8 77.6%  
Inventory Days Days57111 51.2%  
Debtors Days Days14124 11.3%  
Net fixed assets Rs m14,3437,444 192.7%   
Share capital Rs m1,69481 2,092.6%   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,39813,685 156.4%   
Long term debt Rs m24,809 0.0%   
Total assets Rs m39,11325,852 151.3%  
Interest coverage x1,091.0-7.7 -14,109.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.7 118.6%   
Return on assets %11.4-15.2 -75.2%  
Return on equity %20.8-32.1 -64.8%  
Return on capital %31.9-19.8 -161.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,9941,488 268.4%  
From Investments Rs m-1,433-457 313.7%  
From Financial Activity Rs m-3,5844,365 -82.1%  
Net Cashflow Rs m-1,0235,396 -19.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.79 Rs / ZAR

Compare GSK PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: UNICHEM LAB  PLETHICO PHARMA  LUPIN  SUN PHARMA  AJANTA PHARMA  



Today's Market

Bank Credit Growth, World Bank on Developments in India, and Top Cues in Focus Today(Pre-Open)

On Thursday, Indian share markets rose sharply during closing hours and ended on a strong note, extending gains to the fifth day.

Related Views On News

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 16.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 17, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE GSK PHARMA WITH

MARKET STATS